Why Symptom Variability in Chronic Illness Is Not Failure

Key Takeaways

• Predictability does not equal stability in chronic disease management
• Symptom fluctuations are normal biological variability
• Misreading variability heightens patient distress
• Clinicians should reframe expectations toward adaptability
• Stability means tolerating variation, not eliminating it

Summary

Donald Kushner, MD argues that symptom variability in chronic illness is often misread as failure because clinicians and patients equate predictability with stability. He explains that biological systems naturally fluctuate and that chronic disease merely amplifies awareness of this natural variation. By distinguishing predictability from stability, the piece suggests a shift toward viewing variability as an expected, manageable aspect of health. This reframing can reduce distress and improve care strategies for conditions like multiple sclerosis and long‑COVID.

Pulse Analysis

Chronic illnesses such as multiple sclerosis, rheumatoid arthritis, and long‑COVID are characterized by day‑to‑day symptom swings that many patients and providers mistakenly label as failure. Recent commentary by Dr. Donald Kushner highlights a cognitive bias: conflating predictability with stability. While clinicians crave repeatable outcomes for diagnostic confidence, biology is inherently dynamic—blood pressure, hormone levels, and energy fluctuate even in healthy individuals. Recognizing that variability is a physiological norm reframes the clinical narrative from one of loss to one of expected adaptation. Embracing this perspective also aligns with emerging biopsychosocial models that integrate mental resilience into disease management.

This reframing has practical implications for care delivery. When providers treat variability as a warning sign, they may order excessive testing, adjust medications unnecessarily, or inadvertently reinforce patient anxiety. Conversely, framing stability as the capacity to absorb change encourages shared decision‑making, flexible treatment plans, and education that normalizes fluctuation. Health systems can embed this mindset by training clinicians in resilience‑focused communication, integrating patient‑reported outcome measures that capture range rather than single point scores, and designing digital tools that track trends over time. Such an approach also reduces clinician burnout by lowering the pressure to achieve perfect symptom control.

The broader market response reflects growing demand for adaptive health solutions. Wearable sensors, AI‑driven analytics, and tele‑monitoring platforms now emphasize pattern recognition over static thresholds, aligning with the idea that stability tolerates variation. Insurers are also revising reimbursement models to support longitudinal monitoring rather than episodic interventions. By shifting the language from “failure” to “adaptability,” the industry can reduce unnecessary costs, improve patient satisfaction, and foster a more realistic view of chronic disease trajectories. Patients who internalize adaptability report higher quality of life and better adherence to long‑term regimens.